AGBA Acquisition Limited (AGBA)
Company Description
AGBA Group Holding Limited together with its subsidiaries provides wealth management and healthcare institution services in Hong Kong.
The company operates through Platform Business, Distribution Business, Healthcare Business, and Fintech Business segments.
The Platform Business segment operates as a financial supermarket that offers financial products, such as life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, money lending, and real estate agency services.
This segment serves banks, financial institutions, family offices, brokers, and individual independent financial advisors.
The Distribution Business segment provides personal financial advisory services; and financial services and products, including long-term life insurance, savings, and mortgages.
The Healthcare Business segment operates self-operated medical centers and a network of healthcare service providers in the Hong Kong and Macau region.
The Fintech Business segment provides assets and businesses in Europe and Hong Kong. The Fintech Business segment manages financial technology investments with a spectrum of services and value-added information in health, insurance, investments, and social sharing.
The company was formerly known as AGBA Acquisition Limited and changed its name to AGBA Group Holding Limited.
AGBA Group Holding Limited was founded in 1993 and is headquartered in Wan Chai, Hong Kong.
Country | Hong Kong |
Founded | 2018 |
IPO Date | May 14, 2019 |
Industry | Shell Companies |
Sector | Financials |
Employees | 152 |
CEO | Wing Fai Ng |
Contact Details
Address: Room 1108, 11th Fl,block B, New Madison Plaza, 14 Science Museum Rd Tsimshatsui East, Kowloon, K3 OOOOO Hong Kong | |
Phone | 852 3998-4852 |
Stock Details
Ticker Symbol | AGBA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $10.00 |
CIK Code | 0001769624 |
CUSIP Number | G0120M109 |
ISIN Number | VGG012121023 |
SIC Code | 6282 |
Key Executives
Name | Position |
---|---|
Jin Yi Lee | Executive Chairman |
Gordon K. K. Lee | Chief Executive Officer |
Wing Fai Ng | Deputy Chairman |
Pei Huang Shu | Acting Group Chief Financial Officer and Director of Corporate Development |
Jeroen Nieuwkoop | Chief Strategy Officer |
Richard Kong | Deputy Chief Financial Officer and Company Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 1, 2023 | DEF 14A | Other definitive proxy statements |
Nov 20, 2023 | PRE 14A | Other preliminary proxy statements |
Nov 14, 2023 | 8-K | Current Report |
Nov 14, 2023 | 10-Q | Quarterly Report |
Nov 8, 2023 | 8-K | Current Report |
Oct 4, 2023 | 8-K | Current Report |
Oct 3, 2023 | 8-K | Current Report |
Sep 22, 2023 | 8-K | Current Report |
Sep 19, 2023 | 8-K | Current Report |
Sep 7, 2023 | 8-K | Current Report |